Post-IPO Equity Therapeutics Companies

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Medical Aesthetics, Longevity, Anti-Aging, Regenerative Medicine, Wound Care, Human Collagen

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.

BioVie specializes in the development of innovative solutions for the treatment of neurodegenerative and liver diseases.

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.